OptiBiotix Health Plc (AIM:OPTI)
London · Delayed Price · Currency is GBP · Price in GBX 11.08
-0.43 (-3.70%)
Jul 30, 2025, 3:27 PM GMT+1
OptiBiotix Health Revenue
In the year 2024, OptiBiotix Health had annual revenue of 870.00K GBP with 35.09% growth. OptiBiotix Health had revenue of 594.00K in the half year ending December 31, 2024, with 75.74% growth.
Revenue
870.00K
Revenue Growth
+35.09%
P/S Ratio
13.65
Revenue / Employee
87.00K
Employees
10
Market Cap
11.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 870.00K | 226.00K | 35.09% |
| Dec 31, 2023 | 644.00K | 187.00K | 40.92% |
| Dec 31, 2022 | 457.00K | -1.76M | -79.35% |
| Dec 31, 2021 | 2.21M | 689.75K | 45.28% |
| Dec 31, 2020 | 1.52M | 835.66K | 121.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |